AUThOR(s): Bock, E.G.P.

EDITORIAL: More than simply being a review paper and telling the story of the development of a ventricular assist device, this paper aims to critically review changes in technical nomenclature and scientific positioning, taxonomy and its applications, therapeutic indications and the results of its application in patients. After 15 years of the first Brazilian Centrifugal Ventricular Assist Device, many things have changed for the better. Mechanically Assisted Circulatory Support is a therapy consolidated as a safe and effective alternative for the treatment of congestive heart failure, as well as heart transplantation and other drug therapies. It is still seen as science fiction in several countries or media, but that is a cruel reality in our post-truth and fake news times. In reality, it should receive more funding resources especially in developing countries and emerging economies with strong hospital industry of the cardiovascular field that may have surprising results with all the technology already established.